Last reviewed · How we verify
Zolmitriptan oral.
At a glance
| Generic name | Zolmitriptan oral. |
|---|---|
| Sponsor | Parc de Salut Mar |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Cocaine and Zolmitriptan (EARLY_PHASE1)
- Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan. (PHASE1)
- Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011) (PHASE3)
- Efficacy and Safety of Zolmitriptan by Sublingual Administration (PHASE4)
- Treximet ™ Pharmacy Budget Impact Model Database Validation Study
- Comparison of Oral Paracetamol and Zolmitriptan Efficacy in the Treatment of Acute Migraine in Emergency Department (PHASE4)
- Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults (PHASE1)
- A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zolmitriptan oral. CI brief — competitive landscape report
- Zolmitriptan oral. updates RSS · CI watch RSS
- Parc de Salut Mar portfolio CI